SHARE THIS
Two similar global clinical studies were testing a study drug in patients with two rare forms of cancer: Richter’s Syndrome and Diffuse Large B-cell Lymphoma.
Learn how our team helped increase exposure for these rare indications, enabling a steady stream of qualified patients to be directed to over a hundred sites across a total of eight months, resulting in dozens of new screens and randomizations.